Cover Image

PAPERBACK
$43.50



View/Hide Left Panel

Frasch, C.E. 1983. Immunization against Neisseria meningitidis. Pp. 115–144 in Medical Microbiology Volume 2: Immunization Against Bacterial Disease, C.S.F.Easmon and J.Jelijaszewicz, eds. New York: Academic.

Frasch, C.E. 1984. Personal communication, Food and Drug Administration, Bethesda, Md.

Frasch, C.E. 1985. Status of a group B Neisseria meningitidis vaccine. Eur. J.Clin. Microbiol. 4(6):533–536.


Goldschneider, I., E.C.Gotschlich, and M.S.Artenstein. 1969. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1307–1326.

Gotschlich, E.C. 1984. Meningococcal meningitis. Pp. 237–255 in Bacterial Vaccines, R.Germanier, ed. New York: Academic Press.

Greenwood, B.M. 1984. Selective primary health care: Strategies for control of disease in the developing world. XIII. Acute bacterial meningitis. Rev. Infect. Dis. 6(3):374–389.

Greenwood, B.M., P.G.Cleland, M.H.K.Haggie, L.S.Lewis, J.T. MacFarlane, A.Taqi, and H.C.Whittle. 1979. An epidemic of meningococcal infection at Zaria, Northern Nigeria. 2. The changing clinical pattern. Trans. Roy. Soc. Trop. Med. Hyg. 73(5):563–566.

Griffiss, J. McL. 1982. Epidemic meningococcal disease: Synthesis ofa hypothetical immmunologic model. Rev. Infect. Dis. 4:159–172.

Griffiss, J.McL. 1985. Personal communication, University of California School of Medicine, San Francisco, Calif.

Griffiss, J.McL., B.L.Brandt, D.D.Broud, D.K.Goroff, and C.J.Baker. 1984. Immune response of infants and children to disseminated Neisseria meningitidis infection. J. Infect. Dis. 150:71–79.


Käyhty, H., H.Jousimies-Somer, H.Peltola, and P.H.Mäkelä. 1981. Antibody response to capsular polysaccharides of groups A and C Neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease. J. Infect. Dis. 143:32–41.


Lepow, M.L., and L.K.Gordon. 1984. Immunogenicity and safety of PRP-D, a synthetic conjugate of H. influenzae b polysaccharide (PRP) with diphtheria toxoid (D). Abstract 951 in Abstracts of the Twenty-Third Interscience Conference on Antimicrobial Agents and Chemotherapy, Las Vegas, Oct. 24–26, 1983.


Peltola, H. 1983. Meningococcal disease: Still with us. Rev. Infect. Dis. 5:71–91.

Population Reference Bureau. 1984. 1984 World Population Data Sheet. Washington, D.C.: Population Reference Bureau.


Reller, L.B., R.R.MacGregor, and H.N.Beaty. 1973. Bactericidal antibody after colonization with Neisseria meningitidis. J. Infect. Dis. 127:56–62.


Soderstrom, T., G.Hansson, and G.Larson. 1984. The Escherichia coli K1 capsule shares antigenic determinants with the human gangliosides GM3 and GD3. N. Engl. J. Med. 310(11):726–727.


Wali, S.S., J.T.MacFarlane, W.R.C.Weir, P.G.Cleland, P.A.J.Ball, M.Hassan-King, H.C.Whittle, and B.M.Greenwood. 1979. Single injection treatment of meningococcal meningitis. 2. Long-acting chloramphenicol. Trans. Roy. Soc. Trop. Med. Hyg. 73:698–702.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement